Oncothera Advocacy is Shaping the Future of Theranostics
Theranostics combines advanced diagnostic imaging and targeted therapy to support more personalised approaches to healthcare.
Theranostics has the potential to transform patient care, but innovation alone is not enough. Awareness, education, collaboration and access are equally important in ensuring that patients, healthcare professionals and communities can benefit from advances in precision medicine.
Through advocacy initiatives, stakeholder engagement, educational content and thought leadership, Oncothera Advocacy works to support a more informed and connected theranostics ecosystem.
This section brings together the latest insights, perspectives, reports and initiatives shaping the future of theranostics.
Access to Theranostics
Access remains one of the most important considerations in the future of theranostics.
While theranostic approaches are increasingly being adopted in clinical practice, availability can vary depending on geography, healthcare infrastructure, workforce capacity, funding arrangements and awareness among both patients and healthcare professionals.
Improving access requires collaboration across the healthcare ecosystem, including clinicians, researchers, policymakers, healthcare providers, industry and patient advocacy organisations.
Oncothera Advocacy supports conversations and initiatives that contribute to greater awareness and understanding of access-related opportunities and challenges.
Equity in Cancer Care
Every patient deserves the opportunity to receive appropriate information and access to healthcare services, regardless of where they live or their individual circumstances.
As theranostics continues to evolve, consideration must be given to how innovations can be delivered equitably across healthcare systems and communities.
Oncothera Advocacy is committed to supporting awareness, education and dialogue that helps promote equitable access to information, services and future opportunities in theranostics.
Policy & Funding Landscape
The successful integration of new healthcare innovations often depends on a range of policy, regulatory and funding considerations.
As theranostics continues to grow, healthcare systems around the world are exploring how best to support clinical implementation, workforce development, infrastructure requirements and sustainable patient access.
Through engagement with stakeholders across the healthcare ecosystem, Oncothera Advocacy contributes to conversations that help inform understanding of the broader environment influencing theranostics today and into the future.
ADVOCACY INITIATIVES
Advocacy is About More than Awareness
It is about bringing people together to identify challenges, explore opportunities and support meaningful progress. Oncothera Advocacy participates in a range of initiatives designed to encourage education, collaboration and engagement across the theranostics community.
Examples may include:
-
Educational campaigns
-
Community consultation activities
-
Stakeholder engagement initiatives
-
Surveys and research projects
-
Workforce and capability discussions
-
Events and symposiums
-
Awareness programmes
These initiatives help create opportunities for shared learning and collective action. If you want to get involved…
System Barriers & Solutions
As with any emerging area of healthcare, theranostics faces a number of practical and systemic challenges.
These may include:
-
Awareness and education gaps
-
Workforce capacity
-
Infrastructure requirements
-
Regulatory considerations
-
Funding and reimbursement pathways
-
Geographic access challenges
-
Research and evidence generation
Addressing these challenges requires collaboration across multiple stakeholder groups.
By facilitating dialogue and knowledge sharing, Oncothera Advocacy aims to contribute to a stronger understanding of both the barriers and potential solutions that may support future growth.
Reports & Publications
Evidence-informed discussion is essential to the continued development of theranostics.
This section will feature reports, surveys, white papers, consultation outcomes, educational resources and other publications that contribute to greater understanding of the opportunities and challenges facing the sector.
Examples may include:
-
National surveys
-
Consultation reports
-
Industry insights
-
Event summaries
-
White papers
-
Position papers
-
Educational publications
These resources are intended to support informed discussion and encourage collaboration across the healthcare ecosystem.
We can't do this alone - we welcome commercial organisations and government departments to collaborate with us for these initiatives.
ADVOCACY & INSIGHTS
News, Announcements and Education
As Australia's independent voice for theranostics, Oncothera Advocacy provides a neutral platform for thought leadership, education and informed discussion across the healthcare ecosystem.
Through articles, reports, expert perspectives and community initiatives, we aim to be a trusted centre of excellence for theranostics – connecting patients, clinicians, researchers, industry and policymakers while advancing awareness, understanding and collaboration.
Explore the latest insights, developments and conversations shaping the future of theranostics.
Professional & Medical Disclaimer
The information provided within this section is intended for educational and informational purposes only. It does not replace independent clinical judgement, professional guidelines or local regulatory requirements. Healthcare professionals should consult relevant clinical evidence, prescribing information and institutional protocols when making treatment decisions.
Oncothera Advocacy is committed to providing balanced, evidence-informed information and fostering constructive dialogue across the healthcare ecosystem. The views expressed within this section may include a range of perspectives intended to encourage discussion, education and collaboration.